In the realm of pharmaceutical science, the precise control of drug release and formulation stability is paramount. Polymers play a pivotal role in achieving these objectives, and one such critical material is Methacrylic Acid and Methyl Methacrylate Copolymer (1:1), identifiable by its CAS number 25086-15-1. As a specialized manufacturer, we provide this high-quality copolymer, essential for drug delivery applications. If you are looking to buy this polymer, understanding its unique properties and benefits is crucial.

This copolymer, supplied as a white powder, is a functional polymer that offers significant advantages for oral dosage forms. Its primary utility lies in its application as a coating agent for tablets, capsules, and multiparticulates. The hydrophobic nature of the polymer, combined with its ability to form a protective film, offers excellent moisture-proof and light-proof characteristics. This is vital for protecting sensitive Active Pharmaceutical Ingredients (APIs) from environmental degradation, thereby extending shelf life and ensuring product efficacy. For researchers and formulators, sourcing this material from a reputable supplier ensures the consistency needed for reliable product development.

A key feature of CAS 25086-15-1 is its role in enabling delayed intestinal release. This means the polymer coating remains intact in the acidic environment of the stomach and dissolves in the more alkaline conditions of the small intestine, releasing the drug where it can be most effectively absorbed or where it is less likely to cause gastric irritation. This makes it an ideal choice for drugs requiring targeted delivery or those with a narrow therapeutic window. Procurement managers often inquire about the price of such specialized polymers when planning large-scale production.

Furthermore, this copolymer can function as a matrix material. In this capacity, it helps to control the rate at which a drug is released from the dosage form, offering sustained or extended release profiles. This capability is instrumental in improving patient compliance by reducing the need for frequent dosing and maintaining more stable drug plasma levels. For businesses looking to purchase this advanced polymer, partnering with a reliable China-based source like us provides access to quality and cost-effectiveness.

We are committed to providing the pharmaceutical industry with the high-purity materials necessary for innovation. Contact us today to request a sample or a quotation for Methacrylic Acid and Methyl Methacrylate Copolymer (1:1) and discover how we can support your drug delivery challenges.